Glioblastoma Immunotherapy Targeting the Innate Immune Checkpoint CD47-SIRPα Axis

por Hu, Jinyang, Xiao, Qungen, Dong, Minhai, Guo, Dongsheng, Wu, Xudong, Wang, Baofeng
Publicado 2020

Soluble LRIG2 Ectodomain Is Released from Glioblastoma Cells and Promotes the Proliferation and Inhibits the Apoptosis of Glioblastoma Cells In Vitro and In Vivo in a Similar Manne...

por Xiao, Qungen, Tan, Yihu, Guo, Yang, Yang, Hongkuan, Mao, Feng, Xie, Ruifan, Wang, Baofeng, Lei, Ting, Guo, Dongsheng
Publicado 2014

Clinical Features of Craniopharyngioma With Tumoral Hemorrhage: A Retrospective Case-Controlled Study

por Chen, Yusi, Hu, Feng, Wang, Junwen, Huang, Kuan, Liu, Weihua, Tan, Yutang, Zhao, Kai, Xiao, Qungen, Lei, Ting, Shu, Kai
Publicado 2022

Hypoxia-induced HMGB1 promotes glioma stem cells self-renewal and tumorigenicity via RAGE

por Ye, Cuifang, Li, Huan, Li, Yachao, Zhang, Yang, Liu, Guohao, Mi, Hailong, Li, Honglian, Xiao, Qungen, Niu, Li, Yu, Xingjiang
Publicado 2022

LRIG2 promotes the proliferation and cell cycle progression of glioblastoma cells in vitro and in vivo through enhancing PDGFRβ signaling

por Xiao, Qungen, Dong, Minhai, Cheng, Fangling, Mao, Feng, Zong, Weifeng, Wu, Kang, Wang, Heping, Xie, Ruifan, Wang, Baofeng, Lei, Ting, Guo, Dongsheng
Publicado 2018

LRIG2 promotes the proliferation and cell cycle progression of glioblastoma cells in vitro and in vivo through enhancing PDGFRβ signaling

por Xiao, Qungen, Dong, Minhai, Cheng, Fangling, Mao, Feng, Zong, Weifeng, Wu, Kang, Wang, Heping, Xie, Ruifan, Wang, Baofeng, Lei, Ting, Guo, Dongsheng
Publicado 2019

Prognostic significance of ARL9 and its methylation in low-grade glioma

por Tan, Yutang, Zhang, Suojun, Xiao, Qungen, Wang, Junwen, Zhao, Kai, Liu, Weihua, Huang, Kuan, Tian, Weidong, Niu, Hongquan, Lei, Ting, Shu, Kai
Publicado 2020

LRIG2 promotes the proliferation and cell cycle progression of glioblastoma cells in vitro and in vivo through enhancing PDGFRβ signaling

por Xiao, Qungen, Dong, Minhai, Cheng, Fangling, Mao, Feng, Zong, Weifeng, Wu, Kang, Wang, Heping, Xie, Ruifan, Wang, Baofeng, Lei, Ting, Guo, Dongsheng
Publicado 2022

The Prognostic and Therapeutic Potential of LRIG3 and Soluble LRIG3 in Glioblastoma

por Cheng, Fangling, Zhang, Po, Xiao, Qungen, Li, Youwei, Dong, Minhai, Wang, Heping, Kuang, Dong, He, Yue, Duan, Qiuhong, Mao, Feng, Wang, Baofeng, Guo, Dongsheng
Publicado 2019

Corrigendum: The Prognostic and Therapeutic Potential of LRIG3 and Soluble LRIG3 in Glioblastoma

por Cheng, Fangling, Zhang, Po, Xiao, Qungen, Li, Youwei, Dong, Minhai, Wang, Heping, Kuang, Dong, He, Yue, Duan, Qiuhong, Mao, Feng, Wang, Baofeng, Guo, Dongsheng
Publicado 2020

FAM129A promotes self-renewal and maintains invasive status via stabilizing the Notch intracellular domain in glioma stem cells

por Liu, Guohao, Zhang, Po, Chen, Sui, Chen, Zirong, Qiu, Yanmei, Peng, Peng, Huang, Wenda, Cheng, Fangling, Zhang, Yang, Li, Huan, Xiao, Qungen, Mao, Feng, Wang, Baofeng, Jiang, Xiaobing, Wan, Feng, Guo, Dongsheng, Yu, Xingjiang
Publicado 2023

LRIG2 promotes glioblastoma progression by modulating innate antitumor immunity through macrophage infiltration and polarization

por Hu, Jinyang, Dong, Feng, He, You, Xia, Xianyou, Cheng, Fangling, Chen, Sui, Hou, Xiaoshuang, Zhang, Po, Liu, Guohao, Li, Ying, Gao, Qian, Dong, Minhai, Li, Ting, Li, Wei, Xiao, Qungen, Li, Xiaopeng, Yu, Xingjiang, Xi, Guifa, Guo, Dongsheng, Wu, Xudong, Wang, Baofeng
Publicado 2022